Table 1 Association between INAVA expression and clinicopathologic parameters in PTC patients using TCGA dataset
From: INAVA promotes aggressiveness of papillary thyroid cancer by upregulating MMP9 expression
Clinicopathologic variables (n) | INAVA | P value | |
|---|---|---|---|
Low | High | ||
Age (years) | |||
 < 45 (331) | 156 | 175 | 0.070 |
 ≥ 45 (165) | 92 | 73 |  |
Gender | |||
 Male (131) | 62 | 69 | 0.476 |
 Female (365) | 186 | 179 |  |
TNM stage | |||
 I and II (329) | 178 | 151 | 0.010 |
 III and IV (165) | 69 | 96 |  |
 Unknown (2) |  |  |  |
T classification | |||
 T1 and T2 (307) | 167 | 140 | 0.017 |
 T3 and T4 (187) | 81 | 106 |  |
 Unknown (2) |  |  |  |
Lymph node metastasis | |||
 No (227) | 135 | 92 | < 0.001 |
 Yes (219) | 83 | 136 |  |
 Unknown (50) |  |  |  |